Data Bridge Market Research analyzes that the global hepatitis B infection market is expected to reach USD 19.16 billion by 2032 from USD 12.72 billion in 2024, growing with a CAGR of 5.2% in the forecast period of 2025 to 2032.
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Chronic and Acute), By treatment (Vaccine, Antiviral Drugs, Immune Modulator Drugs, and Surgery - Industry Trends and Forecast to 2032
.
The Global Hepatitis B Infection Market size was valued at USD 12.72 USD Billion in 2024.
The Global Hepatitis B Infection Market is projected to grow at a CAGR of 5.2% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico, China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Indonesia, Australia, Vietnam, New Zealand, Taiwan, Philippines, and rest of Asia-Pacific, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Denmark, Norway, Finland, Poland Turkey, and rest of Europe, South Africa, Saudi Arabia, Egypt, Kuwait, Qatar, U.A.E., Oman, Bahrain, and rest of Middle east and Africa, Brazil, Argentina, and rest of South America.
